ArticlePloS one2012

Dominant-negative androgen receptor inhibition of intracrine androgen-dependent growth of castration-recurrent prostate cancer.

Mark A Titus et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.